CNMD logo

CONMED Corporation Stock Price

NYSE:CNMD Community·US$1.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

CNMD Share Price Performance

US$39.80
-29.52 (-42.59%)
US$55.00
Fair Value
US$39.80
-29.52 (-42.59%)
30.2% undervalued intrinsic discount
US$57.00
Fair Value
Price US$39.80
AnalystLowTarget US$57.00
AnalystHighTarget US$68.00
AnalystConsensusTarget US$54.00

CNMD Community Narratives

AnalystLowTarget·
Fair Value US$55 27.6% undervalued intrinsic discount

Rising Costs And Supply Risks Will Impair Future Performance

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value US$80 50.2% undervalued intrinsic discount

Global Aging And Minimally Invasive Trends Will Empower Future Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$54 26.3% undervalued intrinsic discount

Minimally Invasive Surgeries And Robotics Will Boost Global Healthcare

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$80
50.2% undervalued intrinsic discount
Revenue
6.45% p.a.
Profit Margin
9.82%
Future PE
20.22x
Price in 2028
US$100.8
US$55
27.6% undervalued intrinsic discount
Revenue
4.65% p.a.
Profit Margin
8.45%
Future PE
16.88x
Price in 2028
US$68.57

Trending Discussion

Updated Narratives

CNMD logo

CNMD: Margin Expansion And Buyback Program Will Drive Strong Future Returns

Fair Value: US$54 26.3% undervalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CNMD logo

Rising Costs And Supply Risks Will Impair Future Performance

Fair Value: US$55 27.6% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CNMD logo

Global Aging And Minimally Invasive Trends Will Empower Future Markets

Fair Value: US$80 50.2% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with slight risk.

4 Risks
4 Rewards

CONMED Corporation Key Details

US$1.3b

Revenue

US$586.3m

Cost of Revenue

US$761.1m

Gross Profit

US$697.1m

Other Expenses

US$64.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.07
56.49%
4.75%
84.5%
View Full Analysis

About CNMD

Founded
1970
Employees
3900
CEO
Patrick Beyer
WebsiteView website
www.conmed.com

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Recent CNMD News & Updates

Recent updates

No updates